OptiNose Inc

NASDAQ:OPTN  
3.09
-0.04 (-1.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)162.54M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.37 Million
Adjusted EPS-$0.42
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

OptiNose Inc Stock, NASDAQ:OPTN

1020 Stony Hill Road, Suite 300, Yardley, Pennsylvania 19067
United States of America
Phone: +1.267.364.3500
Number of Employees: 204

Description

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.